Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
COPENHAGEN (Reuters) - Novo Nordisk said on Thursday it will launch its hugely popular Wegovy obesity drug in Japan on Feb. 22 next year.
Most patients in Japan will pay 30% of medical expenses for Wegovy, in line with reimbursement for other drugs, a Novo Nordisk spokesperson said.
(Reporting by Jacob Gronholt-Pedersen; Editing by Susan Fenton)
